Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids

被引:27
作者
Nunes, Patricia D. [1 ,2 ,3 ]
Pinto, Joao F. [1 ]
Henriques, Joao [2 ]
Mafalda Paiva, A. [3 ]
机构
[1] Univ Lisbon, Fac Pharm, Res Inst Med iMedUlisboa, P-1649003 Lisbon, Portugal
[2] Hov Farmaciencia SA, R&D Drug Prod Dev, P-1649038 Lisbon, Portugal
[3] Hov Farmaciencia SA, R&D Analyt Dev, P-1649038 Lisbon, Portugal
关键词
amorphous solid dispersions; API surface enrichment; ASD release mechanisms; drug-rich colloids; itraconazole; hydroxypropylmethylcellulose acetate succinate; LIQUID PHASE-SEPARATION; POORLY SOLUBLE DRUGS; ORAL BIOAVAILABILITY; PHYSICAL-CHEMISTRY; IN-VITRO; DISSOLUTION; SOLUBILITY; SUPERSATURATION; FORMULATIONS; ITRACONAZOLE;
D O I
10.1021/acs.molpharmaceut.1c00578
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Understanding the dissolution mechanisms of amorphous solid dispersions (ASDs) and being able to link enhanced drug exposure with process parameters are key when formulating poorly soluble compounds. Thus, in this study, ASDs composed by itraconazole (ITZ) and hydroxypropylmethylcellulose acetate succinate (HPMCAS) were formulated with different polymer grades and drug loads (DLs) and processed by spray drying with different atomization ratios and outlet temperatures. Their in vitro performance and the ability to form drug-rich colloids were then evaluated by a physiologically relevant dissolution method. In gastric media, drug release followed a diffusion-controlled mechanism and drug-rich colloids were not formed since the solubility of the amorphous API at pH 1.6 was not exceeded. After changing to intestinal media, the API followed a polymer dissolution-controlled release, where the polymer rapidly dissolved, promoting the immediate release of API and thus leading to liquid-liquid phase separation (LLPS) and consequent formation of drug-rich colloids. However, the release of API and polymer was not congruent, so API surface enrichment occurred, which limited the further dissolution of the polymer, leading to a drug-controlled release. ASDs formulated with M-grade showed the highest ability to maintain supersaturation and the lowest tendency for AAPS due to its good balance between acetyl and succinoyl groups, and thus strong interactions with both the hydrophobic drug and the aqueous dissolution medium. The ability to form colloids increased for low DL (15%) and high specific surface area due to the high amount of polymer released until the occurrence of API surface enrichment. Even though congruent release was not observed, all ASDs formed drug-rich colloids that were stable in the solution until the end of the dissolution study (4 h), maintaining the same size distribution (ca. 300 nm). Drug-rich colloids can, in vivo, act as a drug reservoir replenishing the drug while it permeates. Designing ASDs that are prone to form colloids can overcome the solubility constraints of Biopharmaceutics Classification System (BCS) II and IV drugs, posing as a reliable formulation strategy.
引用
收藏
页码:51 / 66
页数:16
相关论文
共 59 条
  • [21] Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method
    Hanada, Masataka
    Jermain, Scott V.
    Williams, Robert O., III
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) : 362 - 371
  • [22] Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions
    Hiew, Tze Ning
    Zemlyanov, Dmitry Y.
    Taylor, Lynne S.
    [J]. MOLECULAR PHARMACEUTICS, 2022, 19 (02) : 392 - 413
  • [23] Liquid-Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations
    Ilevbare, Grace A.
    Taylor, Lynne S.
    [J]. CRYSTAL GROWTH & DESIGN, 2013, 13 (04) : 1497 - 1509
  • [24] Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance
    Indulkar, Anura S.
    Lou, Xiaochun
    Zhang, Geoff G. Z.
    Taylor, Lynne S.
    [J]. MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1327 - 1339
  • [25] Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug
    Indulkar, Anura S.
    Gao, Yi
    Raina, Shweta A.
    Zhang, Geoff G. Z.
    Taylor, Lynne S.
    [J]. MOLECULAR PHARMACEUTICS, 2016, 13 (06) : 2059 - 2069
  • [26] Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type
    Jackson, Matthew J.
    Kestur, Umesh S.
    Hussain, Munir A.
    Taylor, Lynne S.
    [J]. MOLECULAR PHARMACEUTICS, 2016, 13 (01) : 223 - 231
  • [27] Review: physical chemistry of solid dispersions
    Janssens, Sandrien
    Van den Mooter, Guy
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (12) : 1571 - 1586
  • [28] Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update
    Jermain, Scott V.
    Brough, Chris
    Williams, Robert O., III
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 535 (1-2) : 379 - 392
  • [29] Tailoring supersaturation from amorphous solid dispersions
    Li, Na
    Taylor, Lynne S.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 279 : 114 - 125
  • [30] Nernst N, 1904, Z PHYS CHEM-STOCH VE, V47, P52